Items where Author is "Brogi, S."

(2026) Dimeric Anthraquinone Rugulosin A Induces Apoptosis in Lung Adenocarcinoma and Targets PI3K/AKT/MAPK Pathways In Silico. Acs Omega. pp. 18744-18759. ISSN 2470-1343

(2026) Integrated structure-based and fragment-guided design of isonicotinic acid derivatives as potential KDM4A inhibitors: an insilico study. Journal of Computer-Aided Molecular Design. p. 24. ISSN 0920-654X

(2025) Combining Subtractive Genomics with Computer-Aided Drug Discovery Techniques to Effectively Target S. sputigena in Periodontitis. Computation. p. 24.

(2025) DNA gyrase-inhibitory antimicrobial anthraquinone from the endophytic Sordariomycetes fungus Diaporthe perseae. Archives of Microbiology. p. 19. ISSN 0302-8933

(2025) In Silico Exploration of Potential Inhibitors Targeting SARS-CoV-2 Non-Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research. Chemical Biology & Drug Design. p. 34. ISSN 1747-0277

(2025) Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation, 2nd Edition. Viruses-Basel. p. 7.

(2024) Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization. Journal of Medicinal Chemistry. pp. 1758-1782. ISSN 0022-2623

(2024) Discovery of novel direct small-molecule inhibitors targeting HIF-2alpha using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations. Molecular diversity. pp. 1203-1224. ISSN 1573-501X (Electronic) 1381-1991 (Linking)

(2024) Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach. Foods. p. 44.

(2024) Natural products as non-covalent and covalent modulators of the KEAP1/ NRF2 pathway exerting antioxidant effects. European Journal of Medicinal Chemistry. p. 35. ISSN 0223-5234

(2024) Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy. Journal of Medicinal Chemistry. pp. 14946-14973. ISSN 0022-2623

(2024) A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients. Biomedicine & Pharmacotherapy. p. 13. ISSN 0753-3322

(2023) Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes. International Journal of Molecular Sciences. p. 23. ISSN 1661-6596

(2023) In Silico Identification of Natural Products and World-Approved Drugs Targeting the KEAP1/NRF2 Pathway Endowed with Potential Antioxidant Profile. Computation. p. 27.

(2023) Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation. Viruses. ISSN 1999-4915 (Electronic) 1999-4915 (Linking)

(2023) Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. Viruses-Basel. p. 21.

(2021) Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening. Comput Biol Med. ISSN 0010-4825 1879-0534 J9 - COMPUT BIOL MED

(2020) Amyloid beta fibril disruption by oleuropein aglycone: long-time molecular dynamics simulation to gain insight into the mechanism of action of this polyphenol from extra virgin olive oil. Food & Function. pp. 8122-8132. ISSN 2042-6496

(2020) Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors. Molecules.

(2019) Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach. Frontiers in Chemistry. p. 20. ISSN 2296-2646

(2019) Synthesis, Molecular odelling and Biological Studies of 3-hydroxypyrane-4-one and 3-hydroxy-nyridine-4-one Derivatives as HIV-1 Integrase Inhibitors. Medicinal Chemistry. pp. 755-770. ISSN 1573-4064

(2019) An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction. Computational Biology and Chemistry. p. 16. ISSN 1476-9271

(2018) Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors. Med Chem. ISSN 1875-6638 (Electronic) 1573-4064 (Linking)